Experimenting With Drugs

While at Stanford in the mid-1960s, One Flew Over the Cuckoo's Nest author Ken Kesey started adding a peculiar ingredient to his homemade venison stew--LSD. Now, more than forty years later, the psychedelic pioneer's beloved drug is giving neuroscientists new clues about what causes schizophrenic psychosis.

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


While at Stanford in the mid-1960s, One Flew Over the Cuckoo's Nest author Ken Kesey started adding a peculiar ingredient to his homemade venison stew—LSD. Now, more than forty years later, the psychedelic pioneer's beloved drug is giving neuroscientists new clues about what causes schizophrenic psychosis. Their research was published this week in the journal Nature.

You've got a lot of chemical messengers naturally swimming in your brain. Serotonin and glutamate are two of them, and they have corresponding receptors to accept their chemical messages.

LSD is a chemical messenger too. When it binds to a serotonin receptor, the hallucinations kick in—but only if the serotonin receptor is hooked up to a glutamate receptor. The neuroscientists say this serotonin-glutamate receptor pair could be the culprit for both hallucinations and mental psychosis

Curiously, when neuroscientists added a chemical messenger to block the glutamate receptor, LSD didn't have any psychedelic effect. There's currently a drug in the second stage of clinical trials that does just that—block the glutamate receptor—and it may bring us one step closer to curing the psychotic symptoms of schizophrenia.

This week's podcast guest hosted by Christopher Intagliata, an intern for Scientific American Mind.

60-Second Psych is a weekly podcast. Subscribe to this Podcast: RSS | iTunes

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe